Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 3/20 | 0.60 |
| ▸ | ATM | Q13315 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | BLM | P54132 | 1/20 | 0.60 |
| ▸ | PLEC | Q15149 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10282637 | 0.92 | ALDH1A1 (0.68) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL30877044 | 0.91 | MAPK1 (0.77) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL27312115 | 0.91 | MAPK1 (0.77) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL27313687 | 0.88 | MAPK1 (0.78) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL1254288 | 0.86 | ALDH1A1 (0.60) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL172677 | 0.86 | ALDH1A1 (0.67) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL1521207 | 0.84 | ALDH1A1 (0.63) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL15782766 | 0.84 | ALDH1A1 (0.65) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL2734546 | 0.84 | ALDH1A1 (0.60) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 | |
| SCHEMBL2399873 | 0.83 | ALDH1A1 (0.58) | MAPK1ALDH1A1KDM4EL3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2019-08-15 | — | — | US | disclosed |
| EP-0696593-A2 | Inhibitors of farnesyl protein transferase | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190248958-A1 | PREPARATION METHOD OF OLIGOMER ADDITIVE, OLIGOMER ADDITIVE, AND LITHIUM BATTERY | PCNA, SCO2, PARG | MAPK1 2264/4885ALDH1A1 3550/4885KDM4E 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.